World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Builder of Novartis Is Stepping Down
Keywords:
Novartis is developing a whole new system for developing pharmaceutical treatments by putting medical science at the centre of things.
12/11/2007
Novartis' CEO Vasella, and Dr Fishman who heads the global research labs in Cambridge, Massachusetts, are redoing the way the company develops drugs and runs the company. Senior leaders are now medically trained scientists, and Novartis has shed much of the old marketing and sales staff. Drug discovery focusses on Dr. Fishman's approach to go after common molecular pathways and develop medicines for diseases that may be rare, but reveal the knowledge behind addressing all diseases that have that common underlying molecular pathway as the source of the diseases functioning.
Grouped Articles
Novartis Chairman Stresses Need for R&D Investment
Wall Street Journal 03/22/2014
Wall Street Journal 12/11/2007
Wall Street Journal 12/17/2007
BusinessWeek 05/08/2008
CEO Gambles on a Novartis Makeover
Wall Street Journal 05/20/2008
BusinessWeek 09/04/2008
Novartis performance
02/04/2010
Grouped Articles
BusinessWeek 02/04/2010
Novartis Hit by Scandal Over Japanese Drug Studies
Wall Street Journal 08/11/2013
Splitting the Pill at Novartis Will Be Easier Said Than Done
Wall Street Journal 11/18/2013
Novartis Starts $5 Billion Share Buyback
Wall Street Journal 11/22/2013
Novartis Seals Purchase of Big Alcon Stake
Wall Street Journal 08/27/2010
Novartis Replaces Top Management in Japan
Wall Street Journal 04/04/2014
Novartis chairman Vasella
01/24/2013
Grouped Articles
Builder of Novartis Is Stepping Down
Wall Street Journal 01/24/2013
Novartis management
02/04/2010
Grouped Articles
BusinessWeek 02/04/2010
Novartis Replaces Top Management in Japan
Wall Street Journal 04/04/2014
Wall Street Journal 07/19/2011
How Novartis Plans to Avoid the 'Patent Cliff'
BusinessWeek 08/04/2011
Wall Street Journal 09/13/2011
At Novartis, the Pill Is Just Part of the Pitch
Wall Street Journal 01/02/2013
Novartis strategies
02/04/2010
Grouped Articles
BusinessWeek 02/04/2010
Splitting the Pill at Novartis Will Be Easier Said Than Done
Wall Street Journal 11/18/2013
Novartis Starts $5 Billion Share Buyback
Wall Street Journal 11/22/2013
Novartis Seals Purchase of Big Alcon Stake
Wall Street Journal 08/27/2010
Novartis Chairman Stresses Need for R&D Investment
Wall Street Journal 03/22/2014
Wall Street Journal 04/23/2014
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us